|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.50 USD | -1.25% |
|
-1.25% | +5.00% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 477M 545M 440M 407M 771M 51.99B 784M 5.26B 2.06B 25.64B 2.05B 2B 88.12B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 430M 490M 396M 366M 694M 46.77B 705M 4.74B 1.86B 23.07B 1.84B 1.8B 79.29B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 day | -1.25% | ||
| 1 week | -1.25% | ||
| Current month | -1.25% | ||
| 1 month | -1.25% | ||
| 3 months | +5.00% | ||
| 6 months | +5.00% | ||
| Current year | +5.00% |
| 1 week | 31.5 | 31.5 | |
| 1 month | 31.5 | 31.5 | |
| Current year | 31.5 | 31.9 | |
| 1 year | 24 | 32.28 | |
| 3 years | 24 | 53.5 | |
| 5 years | 24 | 53.5 | |
| 10 years | 24 | 99.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.25% | -1.25% | - | - | 546M | ||
| +0.95% | -0.08% | -12.82% | -8.16% | 12.85B | ||
| +2.42% | +1.37% | -33.43% | -54.80% | 4.79B | ||
| -0.02% | -0.64% | -6.89% | -5.76% | 4.4B | ||
| -7.84% | -7.31% | +12.48% | -9.74% | 3.68B | ||
| +2.11% | -0.70% | +4.02% | -37.69% | 3.82B | ||
| -0.58% | +6.63% | -8.69% | -13.03% | 3.26B | ||
| +0.28% | +0.57% | -11.39% | +2.92% | 3.1B | ||
| -0.77% | +1.24% | -7.85% | -23.20% | 2.41B | ||
| -0.32% | +4.78% | -5.40% | +44.70% | 1.8B | ||
| Average | -0.50% | -1.14% | -7.77% | -11.64% | 4.46B | |
| Weighted average by Cap. | -0.03% | -1.26% | -9.63% | -14.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 557M 450M 415M 787M 53.08B 800M 5.38B 2.11B 26.18B 2.09B 2.04B 89.98B | 501M 572M 462M 427M 809M 54.56B 822M 5.52B 2.17B 26.91B 2.15B 2.1B 92.48B |
| Net income | 11.34M 12.94M 10.46M 9.65M 18.31M 1.23B 18.6M 125M 48.99M 609M 48.56M 47.51M 2.09B | 32.64M 37.26M 30.11M 27.8M 52.72M 3.55B 53.57M 360M 141M 1.75B 140M 137M 6.02B |
| Net Debt | -49.74M -56.77M -45.88M -42.36M -80.33M -5.42B -81.63M -548M -215M -2.67B -213M -208M -9.18B | -47.86M -54.62M -44.14M -40.76M -77.29M -5.21B -78.54M -528M -207M -2.57B -205M -201M -8.83B |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BOIRF Stock
Select your edition
All financial news and data tailored to specific country editions
















